Lung Cancer Biomarkers and Screening Study

This observational study is looking for better ways to find lung cancer early. Researchers want to identify special markers (biomarkers) in your body that could show if you have lung cancer, even before symptoms appear. You might be able to join if you are 50 or older and have a history of smoking, or if you are being evaluated for suspicious lung nodules. The main goal is to see if these biomarkers can help doctors diagnose lung cancer, which will be checked using CT scans and pathology reports. The study is currently unclear on its recruitment status and plans to enroll over 3600 participants.

Study design
This is an observational study with an unclear status, planning to enroll 3606 participants. It is not testing a specific drug or intervention.
What's involved
You would complete a questionnaire, have lung function tests, a chest CT scan, sputum induction, and blood draws. Some participants might also have a bronchoscopy or lung surgery.
Compensation
Not stated in the trial record.
Follow-up
Lung cancer diagnosis will be measured annually, with the last measurement at 07/01/2015.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00301119

Lung Cancer Biomarkers and Screening

Recruiting
Not specifiedAges 50+Observational
NYU Langone Health
~3,606 participants
Updated 2026-05-08 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Lung cancer diagnosis as measured by CT scan findings and pathology findings annually
Measured over 07/01/2015
Lung Cancer
1 sites across 1 states
New York1
  • James J. Tsay, MD, MSc · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Opens a ready-to-send draft in your own email app — review before sending.

  • Lung cancer diagnosis as measured by CT scan findings and pathology findings annually07/01/2015